The Claim
Creatine monohydrate supplementation at standard doses (3–5 g/day) is not associated with clinically significant renal or hepatic toxicity in adults with type 2 diabetes or older adults, despite transient elevations in serum creatinine due to increased creatine-to-creatinine conversion.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking creatine monohydrate at standard doses does not cause meaningful harm to the kidneys or liver in adults with type 2 diabetes or older adults, even though it may temporarily raise blood creatinine levels due to normal metabolic conversion.
See the scientific wording
Creatine monohydrate supplementation at standard doses (3–5 g/day) is not associated with clinically significant renal or hepatic toxicity in adults with type 2 diabetes or older adults, despite transient elevations in serum creatinine due to increased creatine-to-creatinine conversion.
Creatine draws water into muscle cells, which signals the cells to take in more glucose and store it as glycogen. This improves energy use in muscles and lowers blood sugar without overworking the kidneys or liver. The extra creatine gets turned into creatinine, which temporarily raises a blood marker, but this is just a byproduct — not a sign of damage.
What the research says
1 studyTaking creatine at the usual dose (5 grams a day) didn’t hurt the kidneys or liver in people with type 2 diabetes, even though it made one blood marker go up—which is normal and doesn’t mean anything’s wrong.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.